Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors

SARS-CoV-2 papain-like protease is considered as an important potential target for anti-SARS-CoV-2 drug discovery due to its crucial roles in viral spread and innate immunity. Here, we have utilized an in silico molecular docking approach to identify the possible inhibitors of the SARS-CoV-2 papain-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Daoqun, Luan, Junwen, Zhang, Leiliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698687/
https://www.ncbi.nlm.nih.gov/pubmed/33276953
http://dx.doi.org/10.1016/j.bbrc.2020.11.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698687/
https://www.ncbi.nlm.nih.gov/pubmed/33276953
http://dx.doi.org/10.1016/j.bbrc.2020.11.083

Ejemplares similares